Updated guidance from the IDSA suggests that the clinical utility of COVID-19 antibody testing is limited by the high global seroprevalence of anti-SARS-CoV-2 antibodies.
The AGA has released updated evidence-based recommendations on the EET of Barrett's esophagus and related neoplasms, in which experts call for an individualized approach.
Updated guidance from the IDSA suggests that the clinical utility of COVID-19 antibody testing is limited by the high global seroprevalence of anti-SARS-CoV-2 antibodies.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics including treatment eligibility, diagnostics, and service delivery.